The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 29, 2025
Filed:
May. 13, 2019
Applicants:
Oncoc4, Inc., Rockville, MD (US);
Children's Research Institute, Children's National Medical Center, Washington, DC (US);
Inventors:
Yang Liu, Baltimore, MD (US);
Pan Zheng, Baltimore, MD (US);
Rhonda Flores, Washington, DC (US);
Hung-Yen Chou, McLean, VA (US);
Zhihong Xue, Falls Church, VA (US);
Peiying Ye, Potomac, MD (US);
Martin Devenport, Gaithersburg, MD (US);
Assignees:
OncoC4, Inc., Rockville, MD (US);
Children's Research Institute, Children's National Medical Center, Washington, DC (US);
Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 16/28 (2005.12); A61K 39/00 (2005.12); A61P 35/00 (2005.12);
U.S. Cl.
CPC ...
C07K 16/2896 (2012.12); A61K 39/4611 (2023.04); A61K 39/4631 (2023.04); A61K 39/464429 (2023.04); A61P 35/00 (2017.12); C07K 16/2809 (2012.12); A61K 2039/505 (2012.12); A61K 2239/13 (2023.04); A61K 2239/46 (2023.04); C07K 2317/31 (2012.12); C07K 2317/732 (2012.12);
Abstract
Provided herein are anti-CD24 antibodies that selectively bind human CD24 expressed in cancer cells, but not human CD24 expressed in non-cancerous cells, and the use of such antibodies in cancer therapy.